Treatment

Simultaneous comparison of 25 acute migraine medications: a big data analysis 4:07
Simultaneous comparison of 25 acute migraine medications: a big data analysis
Chia-Chun Chiang • 26 Apr 2023
Advancing myasthenia gravis treatment: RAISE trial of zilucoplan 2:27
Advancing myasthenia gravis treatment: RAISE trial of zilucoplan
James F. Howard Jr. • 26 Apr 2023
Analysis of acute migraine medications: bridging the gap between research & real-world experiences 1:26
Analysis of acute migraine medications: bridging the gap between research & real-world experiences
Chia-Chun Chiang • 26 Apr 2023
Tenecteplase increasingly implemented as standard of care in acute ischemic stroke 1:53
Tenecteplase increasingly implemented as standard of care in acute ischemic stroke
Johanna Ospel • 13 Apr 2023
Association of B-cell subsets and AQP4 antibody titers with disease activity in NMOSD 2:51
Association of B-cell subsets and AQP4 antibody titers with disease activity in NMOSD
Friedemann Paul • 27 Apr 2023
Inebilizumab in AQP4+ NMOSD patients with history of immunosuppression treatment: N-MOmentum study 1:56
Inebilizumab in AQP4+ NMOSD patients with history of immunosuppression treatment: N-MOmentum study
Friedemann Paul • 27 Apr 2023
Using AI to predict epilepsy surgery outcomes 6:27
Using AI to predict epilepsy surgery outcomes
Daniel Goldenholz • 28 Apr 2023
AAN highlights: NMOSD and MOGAD 1:06
AAN highlights: NMOSD and MOGAD
Friedemann Paul • 27 Apr 2023
sGFAP as a biomarker in NMOSD 3:14
sGFAP as a biomarker in NMOSD
Friedemann Paul • 27 Apr 2023
Study design for the PREVAIL trial: Phase III study of ALXN1720 in adults with myasthenia gravis 1:52
Study design for the PREVAIL trial: Phase III study of ALXN1720 in adults with myasthenia gravis
James F. Howard Jr. • 26 Apr 2023
ND0612 vs oral immediate-release levodopa/carbidopa in patients with PD and motor fluctuations 3:31
ND0612 vs oral immediate-release levodopa/carbidopa in patients with PD and motor fluctuations
Alberto Espay • 27 Apr 2023
Zavegepant nasal spray for the acute treatment of migraine with and without aura 3:07
Zavegepant nasal spray for the acute treatment of migraine with and without aura
Timothy Smith • 26 Apr 2023
MS therapies: limited direct effect in CNS pathology 2:29
MS therapies: limited direct effect in CNS pathology
Augusto A. Miravalle • 5 May 2023
Future of tau-directed therapeutics in tauopathies 2:13
Future of tau-directed therapeutics in tauopathies
Boyd Ghosh • 20 Apr 2023
MND-SMART: the adaptive platform trial investigating potential treatments for MND 3:22
MND-SMART: the adaptive platform trial investigating potential treatments for MND
Jane Haley • 24 Apr 2023
Latest developments in stroke neuroprotection 2:04
Latest developments in stroke neuroprotection
Johanna Ospel • 13 Apr 2023
The content of VJNeurology is intended for healthcare professionals